Kapitalisasi pasar Firefly Neuroscience, Inc. (AIFF)

The Firefly Neuroscience, Inc (AIFF) price chart, recorded at 0.02, is based on the use of external cloud systems for data storage and EEG processing during autonomous software development. The robotization of diagnostics via neural networks automates the detection of pathologies, although the final diagnosis is made by a physician. The company is currently entering the monetization stage, engaging psychiatric centers to implement objective dementia tests.

Firefly Neuroscience - Biji pasar AIFF (periode 04.07.2022 - 22.10.2026)

AIFF (Firefly Neuro): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Firefly Neuroscience, Inc (AIFF):

Rega saham Firefly Neuroscience|AIFF - Target median analis|Kapitalisasi pasar AIFF

Analisis fundamental perusahaan:AIFF (Firefly Neuroscience)

Sampel barang fireflyneuro.com

Market capitalization is the product of the current share price and the total number of outstanding shares, reacting instantaneously to shifts in market expectations. This indicator determines the aggregate value of the business, serving as a fundamental measure of its economic weight. For Firefly Neuroscience, Inc (AIFF), the valuation reflects the scaling potential of its AI platform following FDA approval. However, modest clinical adoption is temporarily limiting value growth. The company's market capitalization dynamics clearly demonstrate this transition from a pre-scale plateau to commercial realization.

Pesaing wigati

Kapitalisasi pasar BIIB (Biogen)|Kapitalisasi pasar Neurocrine (NBIX)|Regencell - Kapitalisasi pasar|Biji pasar AXSM|ACAD: Kapitalisasi pasar|Biji pasar XENE (xenon-pharma.com)|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Kapitalisasi pasar|Prothena Corp - Biji pasar|Kapitalisasi pasar ALEC|Kapitalisasi pasar Annexon Biosciences|Nilai pasar Omeros OMER|Nilai pasar NGNE|AC Immune - Kapitalisasi pasar|Nilai pasar voyagertherapeutics.com|NMRA: Kapitalisasi pasar|Biji pasar SCLX (Scilex Holding)|Nilai pasar Tevogen Bio Holdings, Inc.|Nilai pasar ACOG|Biji pasar CGTX (Cognition Therapeutics, Inc.)|IKT - Nilai pasar|Cassava Sciences - Biji pasar|Nilai pasar ASRT|COYA - Nilai pasar|VTGN (Vistagen Therapeutics) - Kapitalisasi pasar|OVID: Kapitalisasi pasar|Nilai pasar acumenpharm.com (ABOS)|Biji pasar CRVO|Kapitalisasi pasar Alterity Therapeutics Ltd|Nilai pasar Clene Inc. (CLNN)|PEPG (pepgen.com) - Nilai pasar|Nilai pasar Jupiter Neurosciences JUNS|relmada.com (RLMD) - Nilai pasar|ANVS - Nilai pasar|Kapitalisasi pasar Grace Therapeutics, Inc. GRCE|KLTO: Kapitalisasi pasar|Biji pasar NeuroSense Therapeutics Ltd.|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|MetaVia, Inc. (MTVA) - Kapitalisasi pasar|Kapitalisasi pasar NRXS|HSDT - Nilai pasar|Nilai pasar Passage Bio PASG|NEUP: Kapitalisasi pasar|Minerva Neurosciences - Kapitalisasi pasar|athira.com (ATHA) - Biji pasar|ADXN: Kapitalisasi pasar|Nilai pasar Alzamend Neuro (ALZN)|Biji pasar CYCN|PTIX: Nilai pasar|Kapitalisasi pasar KTTA|Kapitalisasi pasar cortigent.com|Nilai pasar Avenue Therapeutics, Inc. ATXI|BCLI: Kapitalisasi pasar|Cara Therapeutics, Inc - Kapitalisasi pasar|Chromocell (CHRO) - Biji pasar|ELYM: Kapitalisasi pasar|Intra-Cellular Therapies, Inc. (ITCI) - Kapitalisasi pasar|LBPH (Longboard Pharmaceuticals, Inc.) - Kapitalisasi pasar|Marinus Pharmaceuticals Inc (MRNS) - Kapitalisasi pasar|Kapitalisasi pasar NKGN|NRBO: Biji pasar|Kapitalisasi pasar SAGE (Sage Therapeutics, Inc.)|SNPX (synaptogen.com) - Biji pasar|TRVN - Nilai pasar|VIGL (Vigil Neuroscience) - Kapitalisasi pasar|WENA: Kapitalisasi pasar|Nilai pasar Cerevel Corp (CERE)